CheckMan Stock Market Overview
Trending Stocks
Red List
In Today's Headlines
Investors interested in stocks from the Medical - Products sector have probably already heard of Royal Philips (PHG) and Haemonetics (HAE). But which of these two stocks presents investors with the better value opportunity right now?
Investors with an interest in REIT and Equity Trust - Other stocks have likely encountered both Outfront Media (OUT) and Crown Castle (CCI). But which of these two companies is the best option for those looking for undervalued stocks?
Investors with an interest in Aerospace - Defense stocks have likely encountered both Embraer (ERJ) and Airbus Group (EADSY). But which of these two companies is the best option for those looking for undervalued stocks?
Inspire Medical's (INSP) both geographic segments witness strong revenue growth in the first quarter.
Fidelity National (FIS) revises its adjusted EPS guidance between $4.88 and $4.98, the mid-point of which implies a 46.3% surge from the 2023 figure of $3.37.
Pacira (PCRX) reports first-quarter 2024 results, wherein earnings miss but revenues beat estimates, driven by Exparel sales.
Prosecutors and defense lawyers for Scott Sibella have suggested that a judge file the former MGM Grand casino president to probation in the criminal case.
Dine Brands Global, Inc. (NYSE:DIN ) Q1 2024 Results Conference Call May 8, 2024 9:00 AM ET Company Participants Matt Lee - SVP, Finance and IR John Peyton - CEO Vance Chang - CFO Tony Moralejo - President, Applebee's Jay Johns - President, IHOP Conference Call Participants Eric Gonzalez - KeyBanc Nick Setyan - Wedbush Dennis Geiger - UBS Todd Brooks - The Benchmark Company Brian Vaccaro - Raymond James Operator Good day, and thank you for standing by. Welcome to the Dine Brands First Quarter Earnings Conference Call.
Payoneer Global Inc. (NASDAQ:PAYO ) Q1 2024 Earnings Conference Call May 8, 2024 8:30 AM ET Company Participants Michelle Wang - Vice President-Investor Relations John Caplan - Chief Executive Officer Bea Ordonez - Chief Financial Officer Conference Call Participants Will Nance - Goldman Sachs Mark Palmer - Benchmark Cris Kennedy - William Blair Sanjay Sakhrani - KBW Operator Good morning. Thank you for standing by.
UBS raised its price target on the shares from $63 to $69 and kept a buy rating. The analyst believes Walmart's momentum from the end of fiscal 2024 continued in fiscal 2025's first quarter.